These compounds may interact with:
Lysosomal Pro-X carboxypeptidase
Potentially involved in: carcinoma; c1 inhibitor deficiency; holoprosencephaly; angioedema; astrocytoma; diabetes mellitus; glioblastoma multiforme; intraductal papillary-mucinous carcinoma (ipmc); juvenile dermatomyositis; lung cancer; malignant mesothelioma; non primary sjogren syndrome sicca; oligodendroglioma; ovarian cancer; pancreatic ductal adenocarcinoma liver metastasis; posterior fossa group a ependymoma; urothelial carcinoma; nasal discharge; vasomotor rhinitis; rhinitis
Disease data sourced from Pharos.